BANK OF AMERICA CORP /DE/ - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$950
-15.3%
1,093
+9.1%
0.00%
Q2 2023$1,122
+7.7%
1,0020.0%0.00%
Q1 2023$1,042
-18.0%
1,002
-11.7%
0.00%
Q4 2022$1,271
-36.4%
1,135
-29.5%
0.00%
Q3 2022$2,000
-98.2%
1,611
-97.9%
0.00%
Q2 2022$113,000
-59.1%
77,263
-35.9%
0.00%
Q1 2022$276,000
+2200.0%
120,500
+2760.2%
0.00%
Q4 2021$12,000
-29.4%
4,213
+46.8%
0.00%
Q3 2021$17,000
+21.4%
2,869
-0.8%
0.00%
Q2 2021$14,000
+27.3%
2,891
-33.3%
0.00%
Q1 2021$11,0004,333
+3338.9%
0.00%
Q3 2020$0
-100.0%
126
-97.9%
0.00%
Q3 2019$4,000
-84.0%
6,000
-77.0%
0.00%
Q2 2019$25,000
+257.1%
26,035
+360.6%
0.00%
Q1 2019$7,000
-58.8%
5,653
-64.5%
0.00%
Q4 2018$17,000
-83.8%
15,941
-6.6%
0.00%
Q3 2018$105,000
-40.7%
17,075
+3.0%
0.00%
Q2 2018$177,000
+941.2%
16,574
+915.6%
0.00%
Q1 2018$17,000
-22.7%
1,632
-49.9%
0.00%
Q4 2017$22,000
-63.9%
3,256
-54.0%
0.00%
Q3 2017$61,000
+96.8%
7,075
+104.7%
0.00%
Q2 2017$31,0000.0%3,457
-11.6%
0.00%
Q1 2017$31,000
+93.8%
3,910
+114.5%
0.00%
Q4 2016$16,000
+220.0%
1,823
+520.1%
0.00%
Q3 2016$5,0002940.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders